<DOC>
	<DOCNO>NCT01052792</DOCNO>
	<brief_summary>An open label randomise , two-treatment , two-period , two-sequence , single-dose , crossover , comparative bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Naproxen Sodium 550 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description>The study open label , randomise , two-treatment , two-period , two-sequence , single-dose , crossover , comparative bioequivalence study Naproxen Sodium 550 mg tablet ( contain naproxen 500 mg ) manufacture Dr. Reddy 's Laboratories , ltd , Generics , India compare ANAPROX® DS 550 mg tablet ( contain naproxen 500 mg ) Roche Pharmaceuticals , Roche Laboratories Inc. 340 Kingsland Street , New Jersey ; healthy , adult , human subject feed condition wash period 10 day two period .</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy human subject within age range 18 45 year . Nonsmokers since least six month . Willingness provide write informed consent participate study . Bodymass index ≥ 18.5 kg/m2 ≤ 24.9 kg/m2 , witQ body weight less 50 kg . Absence significant disease clinically significant abnormal laboratory value laboratory evaluation , medical history physical examination screen . Normal 12lead ECG one abnormality consider clinically insignificant . Normal chest Xray PA view . Comprehension nature purpose study compliance requirement protocol . Female Subjects : child bear potential practicing acceptable method birth control duration study judge investigator ( ) condom , foams jelly , diaphragm , intrauterine device { IUD } , abstinence postmenopausal least 1 year , surgically sterile { bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject . Personal/family history allergy hypersensitivity Naproxen sodium ally drug . Past history anaphylaxis angioedema . Any major illness past three month clinically significant ongoing chronic medical illness e.g . congestive heart failure , hepatitis , pancreatitis etc . Presence clinically significant abnormal value screen e.g significant abnormality liver Function Test ( LFT ) , Renal ( kidney ) Function Test ( RFT ) , etc . Any cardiac , renal liver impairment organ system impairment . History seizure psychiatric disorder . Presence disease marker HIV 1 2 , hepatitis B C virus . Consumption alcohol two year , consumption three alcoholic drink per day consumption alcohol within 48 hour prior dose study { one drink equal one unit alcohol { one glass wine half pint beer , one measure ( one ounce ) spirit ] . Consumption xanthine contain derivative ( coffee , tea , cola drink , chocolate ) within 48 hour checkin period . Use recreational drug history drug addiction . Participation clinical trial within past 3 month . Inaccessibility vein leave right arm . Donation blood ( one unit 350 mL ) within 3 month prior receive first dose study medication . Receipt prescription drug therapy within four week overthecounter { OTC ) drug within two week prior receive first dose study medication repeat use drug within last four week . An unusual diet , whatever reason e.g . low sodium diet two week prior receive medication subject 's participation study . Consumption grapefruitcontaining food beverage within 7 day prior receive first dose study medication period . Recent history dehydration diarrhoea , vomit reason within period 24 hour prior study . Female volunteer demonstrate positive pregnancy screen currently breastfeed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Naproxen</keyword>
	<keyword>crossover</keyword>
</DOC>